Probiotics from research to market: the possibilities, risks and challenges

Benoit Foligné, Catherine Daniel, Bruno Pot

Research output: Contribution to journalScientific reviewpeer-review

166 Citations (Scopus)

Abstract

Probiotic foods can affect large parts of the population, while therapeutic applications have a less wide scope. While commercialization routes and regulatory requirements differ for both applications, both will need good scientific support. Today, probiotics are mainly used for gastrointestinal applications, their use can easily be extended to skin, oral and vaginal health. While most probiotics currently belong to food-grade species, the future may offer new functional microorganisms in food and pharma. This review discusses the crosstalk between probiotic producers, regulatory people, medical care and healthcare workers, and the scientific community.

Original languageEnglish
Pages (from-to)284-292
Number of pages9
JournalCurrent Opinion in Microbiology
Volume16
Issue number3
DOIs
Publication statusPublished - Jun 2013

Bibliographical note

Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords

  • Biological Therapy/methods
  • Diet/methods
  • Drug Approval
  • Humans
  • Probiotics/adverse effects

Fingerprint

Dive into the research topics of 'Probiotics from research to market: the possibilities, risks and challenges'. Together they form a unique fingerprint.

Cite this